
    
      All patients with multi-drug resistant pulmonary tuberculosis will be assigned into 2
      groups(study group and control group)，both groups will receive conventional treatment.
      Allogeneic γδT cell will be administrated intravenously to patients in the study group (but
      not the control group) every two weeks for 6 months
    
  